FMISO as a Biomarker for Clinical Radiation Oncology
Author:
Publisher
Springer Berlin Heidelberg
Link
http://link.springer.com/content/pdf/10.1007/978-3-662-49651-0_10
Reference62 articles.
1. Bittner M-I, Wiedenmann N, Bucher S, Hentschel M, Mix M, Weber WA et al (2013) Exploratory geographical analysis of hypoxic subvolumes using (18)F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapy. Radiother Oncol 108(3):511–516
2. Bol A, Labar D, Cao-Pham TT, Jordan B, Grégoire V et al (2015) Predictive value of (18)F-FAZA PET imaging for guiding the association of radiotherapy with nimorazole: a preclinical study. Radiother Oncol 114(2):189–194
3. Bollineni VR, Koole MJB, Pruim J, Brouwer CL, Wiegman EM, Groen HJM et al (2014) Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategies. Radiother Oncol 113(2):198–203
4. Borad MJ, Reddy SG, Bahary N, Uronis HE, Sigal D, Cohn AL et al (2014) Randomized phase II trial of gemcitabine plus TH-302 versus gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol
5. Buijsen J, van Stiphout RG, Menheere PPCA, Lammering G, Lambin P (2014) Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: a prospective, hypothesis driven study on patients with locally advanced rectal cancer. Radiother Oncol 111(2):237–242
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Affinity of PET-MRI Tracers for Hypoxic Cells in Breast Cancer: A Systematic Review;Cells;2024-06-17
2. Molecular imaging of tumor hypoxia: Evolution of nitroimidazole radiopharmaceuticals and insights for future development;Bioorganic Chemistry;2023-10
3. The imaging of the hypoxic microenvironment in tumorous tissue using PET/CT and PET/MRI;European Journal of Radiology;2022-09
4. Theranostics – present and future;Bio-Algorithms and Med-Systems;2021-12-01
5. Hypoxia in Lung Cancer Management: A Translational Approach;Cancers;2021-07-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3